Tapewire

Nasdaq · USD

WTW

WILLIS TOWERS WATSON PLC

Export transactions ↓
Tapewire entity
3139
SEC CIK
0001140536
Parsed reports
1,677

Last 12 months

Inside the activity.

4 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202620
Mar 202601
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 17, 2023 Filed Jul 19, 2023 21:16 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
GrantOrdinary Shares, nominal value $0.000304635 per share 25.494 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021046 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,265.067

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:15 UTC
Thomson-Hall PamelaHead of International
GrantDividend Equivalent Rights- 2021 RSU · Derivative 7.758 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021043 · form4.xml · derivative · entry 3

Thomson-Hall Pamela · CIK 0001947809 · Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53.771

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 7.758 shares

Expires not disclosed

F1 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:15 UTC
Thomson-Hall PamelaHead of International
GrantDividend Equivalent Rights- 2022 RSU · Derivative 1.079 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021043 · form4.xml · derivative · entry 2

Thomson-Hall Pamela · CIK 0001947809 · Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.456

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 1.079 shares

Expires not disclosed

F1 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:15 UTC
Thomson-Hall PamelaHead of International
GrantOrdinary Shares, nominal value $0.000304635 per share 1.935 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021043 · form4.xml · nonDerivative · entry 1

Thomson-Hall Pamela · CIK 0001947809 · Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,651.935

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:13 UTC
Qureshi Imran AhmedHead of North America
GrantDividend Equivalent Rights- 2022 RSU · Derivative 2.509 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021041 · form4.xml · derivative · entry 4

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12.674

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 2.509 shares

Expires not disclosed

F1 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:13 UTC
Qureshi Imran AhmedHead of North America
GrantRestricted Share Unit · Derivative 4.7667 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021041 · form4.xml · derivative · entry 3

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,307.9047

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 4.7667 shares

Expires not disclosed

F4 · derivative.exercise_price: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units.

F4 · derivative.exercise_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · derivative.expiration_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:13 UTC
Qureshi Imran AhmedHead of North America
GrantRestricted Share Unit · Derivative 7.9415 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021041 · form4.xml · derivative · entry 2

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,238.058

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 7.9415 shares

Expires not disclosed

F2 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · shares: Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F2 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:13 UTC
Qureshi Imran AhmedHead of North America
GrantOrdinary Shares, nominal value $0.000304635 per share 3.976 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021041 · form4.xml · nonDerivative · entry 1

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,537.436

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:12 UTC
Krasner Andrew JayChief Financial Officer
GrantDividend Equivalent Rights- 2022 RSU · Derivative 4.166 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021038 · form4.xml · derivative · entry 6

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21.049

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 4.166 shares

Expires not disclosed

F1 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:12 UTC
Krasner Andrew JayChief Financial Officer
GrantDividend Equivalent Rights- 2021 RSU · Derivative 33.036 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021038 · form4.xml · derivative · entry 5

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257.492

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 33.036 shares

Expires not disclosed

F1 · derivative.exercise_price: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.exercise_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F1 · derivative.expiration_date: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:12 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 1.537 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021038 · form4.xml · derivative · entry 4

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 439.0784

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 1.537 shares

Expires not disclosed

F5 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F6 · shares: Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Excess Plan"), including the participant's deferral election under the Excess Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Excess Plan.

F5 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F5 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:12 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 2.4982 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021038 · form4.xml · derivative · entry 3

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 767.8321

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 2.4982 shares

Expires not disclosed

F3 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F4 · shares: Represents dividends acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F3 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F3 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 17, 2023 Filed Jul 19, 2023 21:12 UTC
Krasner Andrew JayChief Financial Officer
GrantOrdinary Shares, nominal value $0.000304635 per share 6.295 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-021038 · form4.xml · nonDerivative · entry 1

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,656.41

F1 · shares: The dividend equivalent rights accrued on the reporting person's previously reported restricted share unit award and will vest based on the same vesting schedule applicable to the underlying award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share.

F2 · balance_after: Reflects minor adjustment to correct the amounts held directly and indirectly by the reporting person.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:09 UTC
Banas Kristy DChief Human Resources Officer
GrantRestricted Share Unit · Derivative 10.2151 $235.08 $2,401.37
Disclosure

SEC source: 0001127602-23-020651 · form4.xml · derivative · entry 2

Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376.7321

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 10.2151 shares

Expires not disclosed

F3 · derivative.exercise_price: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F3 · derivative.exercise_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F3 · derivative.expiration_date: Vested shares under the Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:09 UTC
Banas Kristy DChief Human Resources Officer
GrantRestricted Share Unit · Derivative 48.5224 $235.08 $11,406.65
Disclosure

SEC source: 0001127602-23-020651 · form4.xml · derivative · entry 1

Banas Kristy D · CIK 0001881896 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 624.7456

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 48.5224 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:08 UTC
Qureshi Imran AhmedHead of North America
GrantRestricted Share Unit · Derivative 59.0513 $235.08 $13,881.78
Disclosure

SEC source: 0001127602-23-020649 · form4.xml · derivative · entry 1

Qureshi Imran Ahmed · CIK 0001881795 · Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,230.1165

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 59.0513 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:07 UTC
Pullum AnneHead of Europe
GrantRestricted Share Unit · Derivative 13.4682 $235.08 $3,166.10
Disclosure

SEC source: 0001127602-23-020646 · form4.xml · derivative · entry 2

Pullum Anne · CIK 0001688834 · Head of Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 755.7108

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 13.4682 shares

Expires not disclosed

F3 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F3 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F3 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:07 UTC
Pullum AnneHead of Europe
GrantRestricted Share Unit · Derivative 76.9736 $235.08 $18,094.95
Disclosure

SEC source: 0001127602-23-020646 · form4.xml · derivative · entry 1

Pullum Anne · CIK 0001688834 · Head of Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,703.9106

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 76.9736 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:06 UTC
Kurpis Joseph StephenPAO and Controller
GrantRestricted Share Unit · Derivative 3.4659 $235.08 $814.76
Disclosure

SEC source: 0001127602-23-020644 · form4.xml · derivative · entry 1

Kurpis Joseph Stephen · CIK 0001497048 · PAO and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200.8597

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 3.4659 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:05 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 17.3398 $235.08 $4,076.24
Disclosure

SEC source: 0001127602-23-020642 · form4.xml · derivative · entry 2

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 437.5415

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 17.3398 shares

Expires not disclosed

F3 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F3 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F3 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:05 UTC
Krasner Andrew JayChief Financial Officer
GrantRestricted Share Unit · Derivative 82.3641 $235.08 $19,362.15
Disclosure

SEC source: 0001127602-23-020642 · form4.xml · derivative · entry 1

Krasner Andrew Jay · CIK 0001881781 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 765.3339

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 82.3641 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:04 UTC
Hess Carl AaronDirector · Chief Executive Officer
GrantRestricted Share Unit · Derivative 103.4201 $235.08 $24,312.00
Disclosure

SEC source: 0001127602-23-020641 · form4.xml · derivative · entry 1

Hess Carl Aaron · CIK 0001435988 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,095.0099

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 103.4201 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:03 UTC
Furman MatthewGeneral Counsel
GrantRestricted Share Unit · Derivative 12.7652 $235.08 $3,000.84
Disclosure

SEC source: 0001127602-23-020640 · form4.xml · derivative · entry 2

Furman Matthew · CIK 0001637389 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,239.6388

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 12.7652 shares

Expires not disclosed

F3 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F3 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F3 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:03 UTC
Furman MatthewGeneral Counsel
GrantRestricted Share Unit · Derivative 60.6347 $235.08 $14,254.01
Disclosure

SEC source: 0001127602-23-020640 · form4.xml · derivative · entry 1

Furman Matthew · CIK 0001637389 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,388.4315

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 60.6347 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:02 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
GrantRestricted Share Unit · Derivative 66.6295 $235.08 $15,663.26
Disclosure

SEC source: 0001127602-23-020639 · form4.xml · derivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,143.7802

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 66.6295 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:01 UTC
Faber AlexisChief Operating Officer
GrantRestricted Share Unit · Derivative 12.3917 $235.08 $2,913.04
Disclosure

SEC source: 0001127602-23-020638 · form4.xml · derivative · entry 2

Faber Alexis · CIK 0001882149 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 865.9953

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 12.3917 shares

Expires not disclosed

F3 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F4 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.

F3 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

F3 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

Read SEC document
July 11, 2023 Filed Jul 13, 2023 20:01 UTC
Faber AlexisChief Operating Officer
GrantRestricted Share Unit · Derivative 58.8603 $235.08 $13,836.88
Disclosure

SEC source: 0001127602-23-020638 · form4.xml · derivative · entry 1

Faber Alexis · CIK 0001882149 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,732.4331

Underlying: Ordinary Shares, nominal value $0.000304635 per share · 58.8603 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F2 · shares: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.

F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 20:01 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
SaleOrdinary Shares, nominal value $0.000304635 per share 900 $230.14 $207,129.60
Disclosure

SEC source: 0001127602-23-019981 · form4.xml · nonDerivative · entry 3

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,239.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F3 · price: This transaction was executed in multiple trades at prices ranging from $229.51 to $230.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 20:01 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
SaleOrdinary Shares, nominal value $0.000304635 per share 600 $231.41 $138,844.50
Disclosure

SEC source: 0001127602-23-019981 · form4.xml · nonDerivative · entry 2

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,139.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $231.035 to $231.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 03, 2023 Filed Jul 5, 2023 20:01 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
SaleOrdinary Shares, nominal value $0.000304635 per share 500 $234.82 $117,410.00
Disclosure

SEC source: 0001127602-23-019981 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,739.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

Read SEC document
June 07, 2023 Filed Jun 9, 2023 20:00 UTC
Pullum AnneHead of Europe
SaleOrdinary Shares, nominal value $0.000304635 per share 5,000 $224.45 $1,122,230.00
Disclosure

SEC source: 0001127602-23-018401 · form4.xml · nonDerivative · entry 1

Pullum Anne · CIK 0001688834 · Head of Europe

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,790.5636

F1 · price: This transaction was executed in multiple trades at prices ranging from $224.37 to $224.505. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 20:01 UTC
Gebauer Julie JareckeHead of Health, Wealth &Career
SaleOrdinary Shares, nominal value $0.000304635 per share 2,500 $218.35 $545,868.00
Disclosure

SEC source: 0001127602-23-017339 · form4.xml · nonDerivative · entry 1

Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,239.573

F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter.

F2 · price: This transaction was executed in multiple trades at prices ranging from $218.25 to $218.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:14 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016287 · form4.xml · nonDerivative · entry 2

Tomczyk Fredric J · CIK 0001350921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 955

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:14 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 69 $227.39 $15,689.91
Disclosure

SEC source: 0001127602-23-016287 · form4.xml · nonDerivative · entry 1

Tomczyk Fredric J · CIK 0001350921 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 143 restricted share units granted on April 1, 2023.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:13 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016286 · form4.xml · nonDerivative · entry 2

Hunt Jacqueline · CIK 0001968656 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 955

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:13 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 69 $227.39 $15,689.91
Disclosure

SEC source: 0001127602-23-016286 · form4.xml · nonDerivative · entry 1

Hunt Jacqueline · CIK 0001968656 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 143 restricted share units granted on April 1, 2023.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:12 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016283 · form4.xml · nonDerivative · entry 2

Chipman Stephen M. · CIK 0001968603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 955

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:12 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 69 $227.39 $15,689.91
Disclosure

SEC source: 0001127602-23-016283 · form4.xml · nonDerivative · entry 1

Chipman Stephen M. · CIK 0001968603 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 143 restricted share units granted on April 1, 2023.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:09 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016280 · form4.xml · nonDerivative · entry 2

REILLY PAUL C · CIK 0001240439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,268

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:09 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 359 $227.39 $81,633.01
Disclosure

SEC source: 0001127602-23-016280 · form4.xml · nonDerivative · entry 1

REILLY PAUL C · CIK 0001240439 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 746 restricted share units granted on October 1, 2022.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:06 UTC
Beale Inga KDirector
GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016279 · form4.xml · nonDerivative · entry 2

Beale Inga K · CIK 0001803480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,531

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:06 UTC
Beale Inga KDirector
Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 465 $227.39 $105,736.35
Disclosure

SEC source: 0001127602-23-016279 · form4.xml · nonDerivative · entry 1

Beale Inga K · CIK 0001803480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 968 restricted share units granted on June 8, 2022.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:06 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016277 · form4.xml · nonDerivative · entry 2

Hammond Michael P. · CIK 0001900425 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,531

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:06 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 465 $227.39 $105,736.35
Disclosure

SEC source: 0001127602-23-016277 · form4.xml · nonDerivative · entry 1

Hammond Michael P. · CIK 0001900425 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 968 restricted share units granted on June 8, 2022.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:04 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 1,432 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016276 · form4.xml · nonDerivative · entry 2

Chima Fumbi F. · CIK 0001832507 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,308

F2 · shares: Comprised of 1,432 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:04 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 756 $227.39 $171,906.84
Disclosure

SEC source: 0001127602-23-016276 · form4.xml · nonDerivative · entry 1

Chima Fumbi F. · CIK 0001832507 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 876

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 1,574 restricted share units granted on June 8, 2022.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:03 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 1,322 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016275 · form4.xml · nonDerivative · entry 2

THOMAS PAUL D · CIK 0001281347 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,030

F2 · shares: Comprised of 1,322 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:03 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 698 $227.39 $158,718.22
Disclosure

SEC source: 0001127602-23-016275 · form4.xml · nonDerivative · entry 1

THOMAS PAUL D · CIK 0001281347 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,708

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 1,453 restricted share units granted on June 8, 2022.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:02 UTC GrantOrdinary Shares, nominal value $0.000304635 per share 881 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016274 · form4.xml · nonDerivative · entry 2

Swanback Michelle R · CIK 0001799270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,531

F2 · shares: Comprised of 881 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 17, 2024 and the Issuer's 2024 Annual General Meeting of Shareholders.

Read SEC document
May 17, 2023 Filed May 19, 2023 20:02 UTC Tax withholdingOrdinary Shares, nominal value $0.000304635 per share 465 $227.39 $105,736.35
Disclosure

SEC source: 0001127602-23-016274 · form4.xml · nonDerivative · entry 1

Swanback Michelle R · CIK 0001799270 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 650

F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 968 restricted share units granted on June 8, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.